Acceleron Pharma Inc EV/Sales
What is the EV/Sales of Acceleron Pharma Inc?
The EV/Sales of Acceleron Pharma Inc is 91.88
What is the definition of EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales of companies in the Health Care sector on NASDAQ compared to Acceleron Pharma Inc
What does Acceleron Pharma Inc do?
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Companies with ev/sales similar to Acceleron Pharma Inc
- Eaton Vance Tax-Managed Global Diversified Equity Income Fund has EV/Sales of 90.79
- genedrive plc has EV/Sales of 90.81
- Royce Micro-Cap Trust Inc has EV/Sales of 91.14
- Fairfax India has EV/Sales of 91.22
- Honda Motor has EV/Sales of 91.24
- Novonix has EV/Sales of 91.58
- Acceleron Pharma Inc has EV/Sales of 91.88
- China Huarong has EV/Sales of 91.97
- Zeotech has EV/Sales of 92.09
- Castillo Copper has EV/Sales of 92.20
- Carnival International has EV/Sales of 92.27
- Imagion Biosystems has EV/Sales of 92.51
- Syntonic has EV/Sales of 92.53